The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activity

Related articles

1. Combined inhibition of BETs and HDACs as a potential epigenetics-based therapy for malignant rhabdoid tumor

   This article has 12 authors:

   1. Zebing Liu
   2. Lingyan Zhu
   3. Yuanyuan Li
   4. Yaxian Wen
   5. Jinxuan Wen
   6. Junzhu Zhang
   7. Lingzhao Min
   8. Changsheng Li
   9. Qi Peng
   10. Lisha Wang
   11. Anqi Li
   12. Xiaoqiang Wang

2. The Analysis of the PI3K-AKT-mTOR Pathway and Mitochondria Modulation by a 2-Aminopyridine Compound Using the Metastatic Prostate Cancer Cell Line PC-3

   This article has 6 authors:

   1. Talita Alvarenga Valdes
   2. Sabrina Mendes Botelho
   3. Keli Lima
   4. Carlos Alberto Montanari
   5. João Agostinho Machado Neto
   6. Andrei Leitão

3. Kaempferol restrains the proliferation and invasion of lung adenocarcinoma cells by modulating the IGF-1R/PI3K/AKT signaling pathway and partially reversing EMT suppression

   This article has 3 authors:

   1. Tao Yu
   2. Wanjun Yu
   3. Huaying Wang